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Abstract 
We have examined a synthetic peptide containing the putative leucine zipper domain of the chicken c-myb proto-oncogene using circular dichroism 
(CD) spectroscopy. The peptide adopts an cc-helical structure only at low temperatures and in the presence 2,2,2-trifluoroethanol. 
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1. Introduction 
The leucine zipper is a sequence motif common in 
many transcription factors, which mediates dimerization 
of proteins via hydrophobic interaction [l]. In a leucine 
zipper domain, four to five leucines are spaced by six 
amino acids, the structure of the dimer is an a-helical 
coiled-coil [2]. A coiled-coil leucine zipper requires not 
only the conserved leucines at position d in a given se- 
quence (abcdefg),, also hydrophobic residues in helical 
position a and charged amino acids in the positions e and 
g required to generate an specific dimerization via am- 
phipatic helices [3]. 
After the first publication on the C/EBP leucine zipper 
dimerization motif [4], a variety of other proteins have 
been reported to contain a leucine zipper domain. Most 
of these proteins exhibit sequence-specific DNA-binding 
activities. Usually this activity is mediated structurally 
by a distinct DNA-binding motif, such as helix-loop- 
helix (e.g. c-myc, MyoD [5]), basic-region (e.g. c-fos, 
c-jun [6]) or homeodomain (e.g. athb-1, athb-2 [7]) 
flanked in near vicinity by a leucine zipper domain able 
to form homodimers or heterodimers with other pro- 
teins. In this regard, the putative leucine zipper of the 
c-myb protein is rather unique, since it is substantially 
separated (- 200 amino acids) from the DNA-binding do- 
main [8]. 
The proto-oncogene c-myb encodes a protein of 
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75 kDa which is believed to act as an transcription fac- 
tor. Analysis of its gene product revealed, that it consists 
of three functional domains responsible for DNA-bind- 
ing, transcriptional activation and negative regulation 
[9]. The c-myb protein is phosphorylated in a cell-cycle 
dependant manner [lo], phosphorylation abolishes its 
specific DNA-binding activity which was shown to reside 
in a tripartite imperfect repeat of - 5 1 amino acids at the 
N-terminus [l 11. In each of these repeats three trypto- 
phans are spaced by 18 or 19 amino acids, a motif con- 
served in myb proteins of all species. Furthermore, the 
DNA-binding activity is regulated by the redox status of 
a conserved cysteine at position 130 [12]. A transcrip- 
tional activation and a negative regulatory domain have 
been mapped adjacent to the carboxy-terminus of the 
DNA binding domain [9]. Whereas an acidic patch in the 
transcriptional activation domain, characteristic for 
transcriptional activators, is thought to interact with 
other factors, a putative leucine zipper region is located 
in the negative regulatory domain [13]. Recently it was 
reported, that this zipper mediates in vivo homodimer 
formation of myb proteins which interferes with DNA 
binding [14]. This negative autoregulation of c-myb ac- 
tivity was demonstrated in co-transfection assays and by 
cross-linking synthetic peptides containing the murine 
c-myb leucine zipper. A mutant peptide, in which leuc- 
ines 3 and 4 were replaced by proline, failed to cross-link 
and to dimerize to the wild type protein. However, the 
authors did not provide a direct proof, that the leucine 
zipper adopts an a-helical structure necessary for dimer- 
ization. We therefore examined the putative leucine zip- 
per domain of chicken c-myb with circular dichroism 
spectroscopy. We could demonstrate that an cc-helical 
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structure is adopted only at low temperatures and in the 
presence of 10% 2,2,2-trifluoroethanol. 
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defgabcdefgabcdefgabcdefgabcdefg 
2. Materials and methods 
position 
human MYB 
murine MYB 
chicken MYB 
t$VHQGTILDNVKNLLEFAETLQFIDSFLNTS 
*******?******+******+******+**x 
ljIVHQGTILDNVKNLLEFAETLQFIDSFLNTS 
xc%*** Z******?******X* ****?*** 
The peptides MIVHQGTILDNVKNLLEFAETLQFIDSFLNTS 
(amino acids 375407 of the chicken c-myb protein) and HYND- 
EDPEKEKRIKELELLLMSTENELKG (amino acids 283-311) were 
synthesized on 9050 peptide synthesizer using standard Fmoc-chemis- 
try. Crude peptides were purified by preparative HPLC on a Vydac Cl8 
column. Identity and purity was checked with HPLC (Vydacx C18) and 
ES1 mass spectrometry (Perkin-Elmer, Sciex API III). 
Fig. 1. Comparison of the putative leucine zipper regions of human, 
murine and chicken MYB proteins. Identical positions are marked with 
an asterix, positions d are underlined. 
Circular dichroism (CD) spectra were recorded m a buffer of 30 mM 
potassmm phosphate, pH 7.2, 1 mM EDTA, 0.1 mM dithiothreitol~ 
0.01% (w/v) lubrol (PEDL) and 10% (v/v) 2,2,2-trifluoroethanol at4°C 
in 0.01 cm cuvettes in a Jobin Yvon Dichrograph R.J. Mark III at a 
concentration of 1 &&I. The spectra were analyzed using the program 
CIRCULAR (kindly provided by Dr. F. Peters and Dr. J. Greipel, 
MHH). The temperature-indu~d denaturation of the zipper peptide 
was studied by recording the circular dichroism at 220 nm. The samples 
were heated from 4’C to 50°C with a rate of 10°C h-‘, and cooled 
back to 4°C with the same rate. 
Peptide cross-linkmg was performed as follows: l-3 pg peptide in 
1 ml PTDL buffer (30 mM potassium phosphate, pH 7.2, 10% (v/v) 
2,2.2-t~fluoroethanol, 0.1 mM dIthiothreito1, 0.01% (w/v) lubrol) were 
incubated on ice with 0.0025% (v/v) glutardialdehyde for 60 min. 100 
~1 of a saturated solution of glycine were added, the mixture was then 
kept at room temperature for 30 min. The samples were precipitated 
with trichloro-acetic acid and separated on a 17.5% SDS-tricine-PAGE 
gel. The peptides were visualized with silver-staining. 
3. Results and discussion 
The leucine zipper of c-myb proteins differs in several 
aspects from ‘classical’ leucine zippers such as in GCN4, 
CIEBP, c-jun and c-fos proteins: it is not located adjacent 
to a DNA-binding domain, it does not possess a high 
density of charged amino acids (e.g. 35% in the GCN4 
leucine zipper, 16% in the case of the c-myb leucine 
zipper}, in contrast, 50% of its amino acids are non- 
polar. Furthermore, leucines in position 1 d and 2d of the 
putative c-myb leucine zipper there are a methionine and 
an isoleucine rather than leucine. 
dimerization capacity, with methionine being the most 
and isoleucine being the least acceptable alternative to 
leucine [ 151. ~ethionine and isoleucine in position 1 an 
8 of the putative leucine zipper are conserved in the 
human, murine and chicken c-myb proteins as shown in 
a compilation (Fig. 1). Furthermore, a recent report on 
the dimerization specificity of leucine zippers [3], high- 
lights the importance of salt bridges of amino acids in the 
g and e position (cf. Fig. 1) in dimer formation. There 
are no charged amino acids at these positions in the 
c-myb protein. However, as the c-myb leucine zipper has 
an unusual high content of 50% unpolar amino acids, the 
interface of a dimer would be formed by mainly hydro- 
phobic interactions and not strengthened by salt bridges 
but rather weakend by one repellent electrostatic interac- 
tion (Fig. 2). Thus, it can be anticipated that this struc- 
ture should have only a weak propensity to form a 
dimeric coiled-coil structure. Our CD data support this 
hypothesis: the polypeptide does not show much evaluta- 
tive secondary structure in aqueous solution. We then 
recorded a thermal denaturation profile in the absence 
of trifluoroethanol (Fig. 4f. The polypeptide denatures 
irreversibly at 28°C with a pretransition at 21°C. How- 
ever the addition of 10% 2,2,2-trifluoroethanol, known 
to favour stabilization of secondary structure, allows the 
polypeptide to form an a-helical structure at 4”C, as 
demonstrated in the CD-spectrum (Fig. 3). An a-helix 
content of 90% was calculated according to the proce- 
dure of Chen et al. [16]. 
A substitution of a leucine by methionine or isoleucine 
at position d is tolerable, but leads to a decrease in the 
Since we could detect an a-helical structure in the 
presence of trifluoroethanol in the CD-experiment, we 
Id ie' lg la’ 2d 2e’ 2g 2a’ 3d 3e’ 3g 3a' 4d 4e' 4g 4a' 5d 5e' 
Id' le lg' la 2d' 2e 29' 2a 3d' 3e 39' 3a 4d' 4e 49' 4a 5d' 5e 
Fig. 2. Schematical delineation of the interface of two peptides in the structure of a parallel, two-stranded coiled-coil. The single letter code of amino 
acids is used. Hydrophobic Interaction is expected between the a,a’ and d,d’ positions, no electrostatic interactions are found between g,e’- or 
g’,e-posttions. Repellent interactron is postulated at aspartatic acids in posittons 4a and 4a’. 
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Fig. 3. CD-spectrum of 1 ,u~/,uI zipper peptide in PEDL-buffer with 10% 
(v/v) 2,2,2-trifluoroethanol at4°C. 90% a-helical content can be calcu- 
lated from this spectrum using the procedure of Chen et al. [16]. 
asked the question, whether we could detect dimers of 
the synthetic leucine zipper in solution on a gel filtration 
column, on native PAGE gels or in a chemical cross- 
linking experiment under conditions where the peptide 
is a-helical, i.e. in the presence of 10% trifluoroethanol. 
While the peptide eluted from a Sephadex G50 column 
(1 x 50 cm) as a monomeric species and migrated in a 
native 6% PAGE gel as a monomer, (data not shown), 
we were successful to cross-link the putative leucine zip- 
per peptide with glutardialdehyde to dimers, trimers and 
higher multimers (Fig. 5), whereas the polar peptide 
HYNDEDPEKEKRIKELELLLMSTENELKG was 
not cross-linked. In conclusion, we do not detect dimer 
formation under equilibrium conditions (gel filtration, 
native gel electrophoresis) but under non-equilibrium 
conditions (cross-linking) we detect dimers, trimers and 
multimers. It is possible, that these dimers are coiled- 
coils, but it is more likely that they are aggregates, 
formed via hydrophobic interactions, a result of the high 
content of unpolar amino acids in this region. 
A heptad repeat of leucines occurs widely in many 
proteins for probabilistic reasons, reflecting the role of 
the abundant amino acid leucine in stabilizing hydropho- 
bic surfaces of ol-helices [17]. This motif can be easily 
extended, when substitutions in the leucine positions are 
allowed. The hydrophobic area defined by such ‘mini- 
zippers’ may be important for intermolecular interac- 
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tions [18] or serve as a structural requirement for the 
tertiary structure of a protein without the necessity to 
form parallel dimers of a two-stranded cc-helical coiled 
coil structure as determined for the basic-region leucine 
zipper of GCN4 [2]. 
We have emphasized that the putative leucine zipper 
of the c-myb protein deviates in many aspects from the 
leucine dimerization motif found in other DNA-binding 
proteins, namely in its unusual amino acid composition 
and its distance to the DNA-binding domain. Further- 
more, we show, that a synthetic peptide containing the 
leucine zipper region of c-myb does not dimerize in solu- 
tion under conditions where it adopts an a-helix. The 
CD-data and the fact that the peptide is easily denatured, 
suggest hat the a-helical structure of the isolated leucine 
zipper is not stable under physiological conditions. On 
the other hand, it is conceivable that the trifluoroetha- 
nol-induced stabilizing effect on the a-helical structure of 
the isolated peptide is somehow compensated by the 
flanking amino acids in the full length c-myb protein. A 
highly hydrophobic but unstructured area might be nec- 
essary for the tertiary structure of the protein. 
In conclusion, we show that a peptide containing the 
putative leucine zipper region of the chicken c-myb pro- 
tein can adopt an a-helical structure only at very re- 
Fig. 4. Thermal denaturation profile of the zipper peptide. The relative 
signal is plotted versus the temperature. A small peak at 21°C can be 
interpreted as a pre-transition, total denaturation is achieved at 28°C. 
Shifting the temperature back from 38°C to 4°C yields no regaining in 
structure. 
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Fig. 5. Chemical cross-linking of the leucine zipper peptide with glu- 
tardialdehyde. Lane a. 3 pcg/rnl peptide; lane b, 1 @g/ml peptide. Mole- 
cular weight positions and monomer, dimer, trlmer and multimeric 
species are marked by arrows. The apparent molecular weight of the 
peptide is smaller than determined by calculation. 
stricted conditions: low temperature and the presence of 
a stabilizing agent. We can not rule out the possibility 
that this region is involved in intramolecular interac- 
tions, but we find little evidence that this sequence is 
involved in c-myb homodimer formation via a coiled-coil 
structure. 
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